Πλοήγηση ανά Συγγραφέα "Tsimourtou, V."
-
Association between PIK3C2B gene and Parkinson's disease: evidence for involvement of the PI3K/AKT pathway
Xiromerisiou, G.; Dardiotis, E.; Kountra, P.; Patramani, I.; Vogiatzi, C.; Katsavaki, M.; Tsimourtou, V.; Ralli, S.; Markou, K.; Papadimitriou, A.; Hadjigeorgiou, G. (2010) -
Association of alpha-synuclein Rep1 polymorphism with risk for Parkinson's disease and influence on age at onset of Parkinson's disease
Xiromerisiou, G.; Gourbali, V.; Aggelakis, K.; Dardiotis, E.; Tsimourtou, V.; Papadimitriou, A.; Papakonstantinou, I.; Scarmeas, N.; Singleton, A.; Hadjigeorgiou, G. (2005) -
BDNF haplotype tagging SNPs in Greek sporadic PD patients and patterns of linkage disequilibrium
Xiromerisiou, G.; Tsimourtou, V.; Gourbali, V.; Aggelakis, K.; Dardiotis, E.; Dardioti, M.; Noulas, G.; Papadimitriou, A.; Singleton, A.; Hadjigeorgiou, G. (2006) -
BDNF tagging polymorphisms and haplotype analysis in sporadic Parkinson's disease in diverse ethnic groups
Xiromerisiou, G.; Hadjigeorgiou, G. M.; Eerola, J.; Fernandez, H. H.; Tsimourtou, V.; Mandel, R.; Hellstrom, O.; Gwinn-Hardy, K.; Okun, M. S.; Tienari, P. J.; Singleton, A. B. (2007)Experimental and clinical data suggest that genetic variations in brain-derived neurotrophic factor (BDNF) gene may affect risk for Parkinson's disease (PD). We performed a case-control association analysis of BDNF in three ... -
Genetic basis of Parkinson disease
Xiromerisiou, G.; Dardiotis, E.; Tsimourtou, V.; Kountra, P. M.; Paterakis, K. N.; Kapsalaki, E. Z.; Fountas, K. N.; Hadjigeorgiou, G. M. (2010)Over the past few years, considerable progress has been made in understanding the molecular mechanisms of Parkinson disease (PD). Mutations in certain genes are found to cause monogenic forms of the disorder, with autosomal ... -
Interleukin 1 receptor antagonist (IL 1RN) and interleukin 1B (IL 1B) gene polymorphisms and primary intracerebral hemorrhage (ICH)
Dardiotis, E.; Dardioti, M.; Tasiou, A.; Aggelakis, K.; Paterakis, K.; Tsimourtou, V.; Noulas, G.; Komnos, A.; Karantanas, A.; Papadimitriou, A.; Hadjigeorgiou, G. (2005) -
Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms in Greek multiple sclerosis (MS) patients with bout-onset MS
Aggelakis, K.; Zacharaki, F.; Dardiotis, E.; Xiromerisiou, G.; Tsimourtou, V.; Ralli, S.; Gkaraveli, M.; Bourpoulas, D.; Rodopoulou, P.; Papadimitriou, A.; Hadjigeorgiou, G. (2010)We investigated the association of specific polymorphisms of the interleukin IL-1b (AvaI -511 and TaqI +3,953) and IL-1 receptor antagonist (IL-1RN) (a variable number of tandem repeats; VNTR) genes with both the susceptibility ... -
Lack of Association of the UCHL-1 Gene with Parkinson's Disease in a Greek Cohort: A Haplotype-Tagging Approach
Xiromerisiou, G.; Kyratzi, E.; Dardiotis, E.; Bozi, M.; Tsimourtou, V.; Stamboulis, E.; Ralli, S.; Vassilatis, D.; Gourbali, V.; Kountra, P. M.; Fountas, K.; Papadimitriou, A.; Stefanis, L.; Hadjigeorgiou, G. M. (2011) -
Low RLS prevalence and awareness in central Greece: an epidemiological survey
Hadjigeorgiou, G. M.; Stefanidis, I.; Dardiotis, E.; Aggellakis, K.; Sakkas, G. K.; Xiromerisiou, G.; Konitsiotis, S.; Paterakis, K.; Poultsidi, A.; Tsimourtou, V.; Ralli, S.; Gourgoulianis, K.; Zintzaras, E. (2007)Restless legs syndrome (RLS) is a sensorimotor disorder with a general population prevalence of 3-10%. A single, previous epidemiological study performed in southeast Europe reported the lowest prevalence rate amongst ... -
Multiple sclerosis and autoimmune liver diseases
Aggelakis, K.; Tsimourtou, V.; Rigopoulou, E.; Noulas, G.; Dardiotis, E.; Dalekos, G.; Papadimitriou, A.; Hadjigeorgiou, G. (2005) -
Paraoxonase 1 (PON1) gene polymorphisins (M55L and Q192R) and osteonecrosis of the femoral head with and without cerebral white matter lesions
Hadjigeorgiou, G. M.; Dardioti, M.; Dardiotis, E.; Aggelakis, K.; Xiromerisiou, G.; Tsimourtou, V.; Noulas, G.; Malizos, K.; Zimbis, A.; Papadimitriou, A.; Karantanas, A. (2005) -
A quantitative evaluation of damage in normal appearing white matter in patients with multiple sclerosis using diffusion tensor MR imaging at 3 T
Gratsias, G.; Kapsalaki, E.; Kogia, S.; Dardiotis, E.; Tsimourtou, V.; Lavdas, E.; Kousi, E.; Pelekanou, A.; Hadjigeorgiou, G. M.; Fezoulidis, I. (2015)The white matter (WM) of the brain is damaged in multiple sclerosis (MS), even in areas that appear normal on standard MR imaging. The purpose of our study is to evaluate the damage of normal appearing white matter (NAWM) ... -
Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant PD: identification of two novel LRRK2 variants
Yiromerisiou, G.; Gourbali, V.; Dardiotis, E.; Dardioti, M.; Tsimourtou, V.; Aggelakis, K.; Papakonstaninou, I.; Noulas, G.; Papadimitriou, A.; Singleton, A.; Hadjigeorgiou, G. (2006)